Patients with psoriasis treated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) have a lower risk of death and major cardiovascular events, compared to those taking other diabetes or weight-loss medications, a large-scale cohort study has found
Long-term weight maintenance on tirzepatide requires continued medication use in most patients
In the first three months, gradual weight loss is common as the dose is titrated up
This helps you track its age and adhere to your research timeline
GI side effects may increase : Nausea, constipation, or diarrhea are more common when starting Wegovy
GLP-1R activation in preclinical models has been associated with enhanced insulin secretion in a glucose-dependent manner, slowed gastric emptying, and modulation of hypothalamic appetite-signaling circuits